A liquid biopsy that measures circulating lung tumor DNA at the end of treatment identifies patients with early NSCLC with a poor prognosis.
A recent survey found that 90% of patients treated with radiation therapy for breast cancer found their experiences to be less “scary” than anticipated.
Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma.
Almost 50% of patients with cancer who experience severe distress miss at least one radiation therapy appointment and are admitted to the hospital during their treatment.
The US Food and Drug Administration has approved a therapy to treat adults with advanced, metastatic breast cancer that has progressed on endocrine therapy.
A precision medicine support tool helps oncologists make clinical decisions and enroll patients in genotype-matched trials based on actionable mutations.
Patients with asymptomatic severe aortic stenosis who do not adhere to guidelines for serial clinical evaluations are at a higher risk for all-cause mortality and heart failure hospitalization.
Many patients with stage IV metastatic cancer achieve stable disease after treatment with radiation therapy and immunotherapy.
Use of active surveillance for very low-risk prostate cancer rose 15.7% over a 3-year span and continues to rise, but rates are still low.
In a recent phase III trial, researchers compared the safety and efficacy of a maintenance therapy vs observation after ASCT in patients with a certain type of B-cell malignancy.